Company | Price d* | Change d* | Volume, Avg. k, d* | Market Cap. d* | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding d* | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Drug Manufacturers—Specialty & Generic Average | - - | - - | - - | 606,071.74 | 29,942.59 | 1,431.11 | 106,807.11 | -688.03 | 0.15 | 20.3000 | 36.12 | 30.9854 | -126.4111 | 0.19 | 4.16 | 192.2432 | - - | ||
Maximum | - - | - - | - - | 10,869,851.00 | 444,593.00 | 12,710.00 | 1,955,691.00 | 6,978.00 | 1.00 | 268.1192 | 319.88 | 93.1700 | 69.5400 | 7.56 | 145.73 | 1,374.4000 | - - | ||
Minimum | - - | - - | - - | 0.00 | 0.00 | -101.00 | -13,707.00 | -17,092.00 | 0.00 | -183.3601 | -0.63 | -392.5400 | -4,237.3100 | -30.79 | -89.90 | 0.0000 | - - | ||
Neurocrine Biosciences, Inc. NBIX | 120.46 | 0.61 0.51% | 787 vs. 925 | 12,163.00 | 515.00 | 43.00 | 119.00 | -113.00 | 0.4300 | 81.2772 | 0.00 | 97.52 | 8.42 | 1.82 | 1.25 | 233.03 | 100.00 | ||
Evotec SE EVOTF | 7.10 | 0.00 0.00% | 0 vs. 0 | 1,258.00 | 208.00 | -20.00 | -86.00 | -496.00 | -0.1200 | -20.3101 | 0.00 | 16.65 | -9.90 | -1.87 | -0.94 | 163.37 | 177.00 |